Read Time: 4 minutes
Recipients were chosen in part for their pledge to focus on research designed to advance cancer prevention and survival in minority populations, improve treatments.
, a nonprofit started by Qualtrics and fueled by thousands of private donors, announced today that seven new cancer researchers will get a boost for their work thanks to $1.1 million in grants.
The five women and two men, who are part of the multi-year 5 For The Fight Cancer Research Fellows program, were vetted and chosen in part for their pledge to focus on research designed to:
- Advance cancer prevention and survival in minority populations
- Create more effective treatment approaches for gynecological cancer
- Find new methods of imaging for pediatric cancers
- Better understand cellular changes that can lead to cancer and other diseases
- Advance development of new clinical trials & treatments for leukemia
- Understand how and why certain tumors resist treatments
- Engineer strategies to safely amplify the body’s immune response to cancer
“What these cancer researchers have in common is grit and innovation,” saidMike Maughan, 5 For The Fight Co-Founder. “Their important work – along with the work of other fellows in the program – bring us one step closer to our goal to eradicate cancer. We are excited to fuel their progress and help give them a real chance to advance the field and help mentor those that come after them.”
This is the third class of 5 For The Fight Cancer Research Fellows, which now totals over 30 researchers. Each researcher receives funding for three years and provides updates on findings annually. 5 For The Fight also has 15 cancer centers through other grants. Past 5 For The Fight Fellows have reported progress on research in colon cancer screenings for Black and Indigenous men, the study of how and why melanomas form, and the role of B cells in solid tumors, among other achievements. To date, 5 For The Fight has raised nearly $30 million to help eradicate cancer with 100% of those funds donated directly to the world’s leading cancer researchers.
All seven of the new fellowship recipients are located at Huntsman Cancer Institute at the 㽶Ƶ of Utah. These fellows were evaluated and selected by a committee of Huntsman Cancer Institute senior leaders: Senior Director of Cancer Training and Career Enhancement, Chief Academic Officer, Senior Director of Basic Science, Senior Director of Population Sciences, Senior Director Preclinical Translation, and Sachin Apte, MD MBA Chief Clinical Officer of Huntsman Cancer Institute and Physician-in-Chief of Huntsman Cancer Hospital.
For information on how to donate to support future fellows as well as other cancer researchers, please visit
2022-2025 5 For The Fight Cancer Research Fellows
Robert L. Dood, MD, MSCE is fighting to improve survival rates in people with gynecologic cancers. Dood is a surgeon-scientist specializing in gynecologic cancer at Huntsman Cancer Institute and an assistant professor of obstetrics and gynecology at the 㽶Ƶ of Utah. Dood will pursue research to better understand specific tumor traits, and use these findings to advance insights into more effective treatment approaches. Dood completed his medical degree and a master of epidemiology at the 㽶Ƶ of Pennsylvania, followed by fellowship training in gynecologic oncology at the 㽶Ƶ of Texas M.D. Anderson Cancer Center.
is fighting to improve imaging in pediatric cancer patients. Imaging is a tool used by doctors to assess whether a patient is responding to treatment. Goel is a pediatric cancer researcher at Huntsman Cancer Institute and an assistant professor of pharmaceutics and pharmaceutical chemistry at the 㽶Ƶ of Utah. Goel will advance study of new methods of imaging for pediatric cancers. She completed her PhD in materials science at the 㽶Ƶ of Wisconsin, followed by postdoctoral training in nanomedicine and cancer systems imaging at the 㽶Ƶ of Texas M.D. Anderson Cancer Center.
is fighting to prevent cancers and improve outcomes in African American and Black immigrant populations through genetic testing and more effective communication. A cancer population scientist at Huntsman Cancer Institute and associate professor of communication at the 㽶Ƶ of Utah, Lumpkins will test new tools to improve communication about reducing cancer risk in minority populations. Lumpkins received her doctorate from the 㽶Ƶ of Missouri-Columbia and holds masters degrees in media communications and management from Webster 㽶Ƶ in St. Louis, Missouri.
is fighting to understand the underlying cellular changes that can lead to cancer and other diseases. A cancer biochemist at Huntsman Cancer Institute and assistant professor of biochemistry at the 㽶Ƶ of Utah, Miller is working to answer fundamental questions about how microscopic changes in chromosomes can lead to defects that precipitate the development of diseases like cancer, and to use these insights to inform more effective strategies for prevention and treatment. Miller received his PhD in cell biology from the Massachusetts Institute of Technology, followed by postdoctoral training in biochemistry and biophysics at the Fred Hutchinson Cancer Research Center.
Ami Patel, MD is fighting to develop better treatments that will improve outcomes for people with blood cancers. She is a physician-scientist at Huntsman Cancer Institute and an assistant professor of internal medicine at the 㽶Ƶ of Utah. Patel cares for patients with leukemia and will use the fellowship award to advance development of new clinical trials to assess treatments that will target leukemia cells. She completed medical training and an internal medicine residency at Northwestern 㽶Ƶ, followed by fellowship training in hematology-oncology at the Salt Lake Veterans Affairs Medical Center and 㽶Ƶ of Utah.
is fighting to understand how certain tumor characteristics resist treatments. Reeves oversees a cancer research laboratory at Huntsman Cancer Institute and is an assistant professor of pathology at the 㽶Ƶ of Utah. Reeves studies a tumor trait called heterogeneity. Heterogeneous tumors respond poorly to immunotherapy, and are common across many tumor types, including melanoma, lung cancer, bladder cancer, and kidney cancer. Yet they are resistant to all available treatments. Reeves plans to understand the barriers the immune system encounters fighting heterogeneous tumors and develop treatment strategies that will improve outcomes for patients. She completed her PhD in biomedical sciences from 㽶Ƶ of California San Francisco.
, is a cancer immunologist at Huntsman Cancer Institute and assistant professor of pathology at the 㽶Ƶ of Utah. She is fighting to understand how to safely deliver immunotherapy treatments for certain types of cancer. Almost all cancers can benefit from immunotherapy treatment - meaning treatments that harness a patient’s own immune system to fight their tumor. Yet some internal systems in the patient’s immune system can create resistance to treatments. Young aims to engineer strategies that safely amplify the immune response to cancer. She completed a PhD in immunology from the 㽶Ƶ of Queensland, and postdoctoral training in tumor immunology and autoimmunity from 㽶Ƶ of California San Francisco.
Media Contact
Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu
About Huntsman Cancer Institute at the 㽶Ƶ of Utah
Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.